Biographical Sketch
Eric Roselli, MD, is a Staff Surgeon in the Cleveland Clinic Department of Thoracic and Cardiovascular Surgery. He is certified by the American Board of Surgery and the American Board of Thoracic Surgery. Dr. Roselli’s specialty interests include adult cardiac surgery, thoracic aortic surgery, endovascular approaches to cardiothoracic diseases, minimally invasive valve repair and replacement, high-risk valve surgery, endovascular stent and prosthetic valve research and cardiovascular imaging.
Dr. Roselli did his undergraduate work at the University of Michigan where he received the David J. Hallisey Memorial Academic Scholarship. He received his medical degree from Loyola University Chicago Stritch School of Medicine, graduating in 1997 “with distinction.” He completed a residency in surgery at Cleveland Clinic followed by a second residency in thoracic and cardiovascular surgery at Cleveland Clinic. He was appointed to Cleveland Clinic in 2005 in the Department of Thoracic and Cardiovascular Surgery.
He has authored or co-authored book chapters and articles in peer-reviewed journals on thoracoabdominal aortic aneurysms, endovascular aortic surgery, reoperative cardiac surgery, aortic valve disease, cardiac CT, atrial fibrillation and heart and lung transplantation.
Dr. Roselli is a Fellow of the American College of Surgeons, and a member of the Society of Thoracic Surgeons, the American College of Cardiology, the International Society of Endovascular Specialists, the International Society of Minimally Invasive Cardiac Surgery and the Society of Cardiovascular Computed Tomography.
Specialty Interests
adult cardiac surgery, thoracic aortic surgery, endovascular approaches to cardiothoracic diseases, minimally invasive valve repair and replacement, high-risk valve surgery, endovascular stent and prosthetic valve research
Additional Training
Endovascular Surgery Fellowship, Cleveland Clinic
Innovations & Patents
Dr. Roselli is one of only a few "hybrid" specialists trained in both open surgical and interventional techniques for the treatment of complex structural heart (aortic and mitral valve) and thoracic aortic disease (aneurysms and dissection).
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate
with the pharmaceutical or medical device industries
to help develop medical breakthroughs or provide
medical education about recent trends. The
collaborations are reviewed as part of the Cleveland
Clinic’s procedures. The Cleveland Clinic publicly
discloses payments to its physicians and scientists
for speaking and consulting of
$5,000 or more per year, and any equity, royalties,
and fiduciary relationships in companies with which
they collaborate. In publicly disclosing this
information, the Cleveland Clinic tries to provide
information as accurately as possible about its
doctors’ connections with industry and those of their
immediate family members. As of 9/4/2008, Dr.
Roselli has reported the financial relationships
with the companies listed below. Patients should feel
free to contact their doctor about any of the
relationships and how the relationships are overseen
by the Cleveland Clinic. To learn more about the
Cleveland Clinic’s policies on collaborations with
industry and innovation management, go to
our Integrity in Innovation page.
Consulting. Dr. Roselli receives fees of $5,000 or more per year as a paid consultant or speaker for the following companies:
Medtronic, Inc.
